IL215990A0 - Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders - Google Patents
Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disordersInfo
- Publication number
- IL215990A0 IL215990A0 IL215990A IL21599011A IL215990A0 IL 215990 A0 IL215990 A0 IL 215990A0 IL 215990 A IL215990 A IL 215990A IL 21599011 A IL21599011 A IL 21599011A IL 215990 A0 IL215990 A0 IL 215990A0
- Authority
- IL
- Israel
- Prior art keywords
- phosphotetrahydfropyran
- wounds
- compounds
- treatment
- fibrotic disorders
- Prior art date
Links
- 206010052428 Wound Diseases 0.000 title 1
- 208000027418 Wounds and injury Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000003176 fibrotic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17341609P | 2009-04-28 | 2009-04-28 | |
| PCT/IB2010/000960 WO2010125445A1 (en) | 2009-04-28 | 2010-04-28 | Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL215990A0 true IL215990A0 (en) | 2012-01-31 |
Family
ID=43031758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL215990A IL215990A0 (en) | 2009-04-28 | 2011-10-27 | Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8557783B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2424542A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2012525369A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20120049183A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010243314C1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2760253A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL215990A0 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ596419A (cg-RX-API-DMAC7.html) |
| SG (1) | SG175816A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010125445A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2926480A1 (en) * | 2012-11-15 | 2014-05-22 | Tufts University | Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor |
| JP7466927B2 (ja) * | 2018-08-10 | 2024-04-15 | ニューヨーク ユニバーシティ | アンジェルマン症候群及び自閉症を治療するためのｉｇｆ―２受容体作動剤リガンドの使用 |
| WO2020033972A1 (en) | 2018-08-10 | 2020-02-13 | New York University | Use of mannose 6 phosphate and modifications thereof for memory enhancement and reducing memory impairment |
| CN113301925A (zh) | 2018-12-19 | 2021-08-24 | 小利兰·斯坦福大学理事会 | 用于溶酶体靶向的双官能分子以及相关的组合物和方法 |
| CN113368106B (zh) * | 2020-02-25 | 2023-09-29 | 渐宽(苏州)生物科技有限公司 | 艾托莫德用于防治特发性肺纤维化的药物中的用途 |
| CN113288890B (zh) * | 2021-06-21 | 2022-02-22 | 南方医科大学南方医院 | N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用 |
| CA3226269A1 (en) | 2021-07-14 | 2023-01-19 | Lycia Therapeutics, Inc. | Asgpr cell surface receptor binding compounds and conjugates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ872300A0 (en) * | 2000-07-11 | 2000-08-03 | Praxis Pharmaceuticals Pty Ltd | Compounds and methods |
| DE602004022659D1 (de) * | 2003-05-20 | 2009-10-01 | Pharmaxis Pty Ltd | Mannose-6-phosphonat-verbindungen zur behandlung von entzündungskrankheiten |
| FR2930942B1 (fr) | 2008-05-07 | 2011-03-04 | Centre Nat Rech Scient | Nouvelles utilisations de derives de d-mannopyranose activateurs de l'angiogenese |
| FR2930943B1 (fr) | 2008-05-07 | 2011-03-18 | Centre Nat Rech Scient | Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese |
-
2010
- 2010-04-28 JP JP2012507839A patent/JP2012525369A/ja active Pending
- 2010-04-28 WO PCT/IB2010/000960 patent/WO2010125445A1/en not_active Ceased
- 2010-04-28 US US13/318,065 patent/US8557783B2/en not_active Expired - Fee Related
- 2010-04-28 EP EP10769382A patent/EP2424542A4/en not_active Withdrawn
- 2010-04-28 NZ NZ596419A patent/NZ596419A/en not_active IP Right Cessation
- 2010-04-28 AU AU2010243314A patent/AU2010243314C1/en not_active Ceased
- 2010-04-28 KR KR1020117028281A patent/KR20120049183A/ko not_active Withdrawn
- 2010-04-28 CA CA2760253A patent/CA2760253A1/en not_active Abandoned
- 2010-04-28 SG SG2011079274A patent/SG175816A1/en unknown
-
2011
- 2011-10-27 IL IL215990A patent/IL215990A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2424542A4 (en) | 2012-12-19 |
| EP2424542A1 (en) | 2012-03-07 |
| JP2012525369A (ja) | 2012-10-22 |
| NZ596419A (en) | 2014-01-31 |
| US20120045455A1 (en) | 2012-02-23 |
| WO2010125445A1 (en) | 2010-11-04 |
| AU2010243314A1 (en) | 2011-12-01 |
| KR20120049183A (ko) | 2012-05-16 |
| AU2010243314B2 (en) | 2015-07-02 |
| SG175816A1 (en) | 2011-12-29 |
| AU2010243314C1 (en) | 2015-11-12 |
| CA2760253A1 (en) | 2010-11-04 |
| US8557783B2 (en) | 2013-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL217901A0 (en) | Treatment of bdnf-related disorders using laquninimod | |
| ZA201202596B (en) | Compounds for the treatment of dyslipidemia and related diseases | |
| GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
| SI2427193T1 (sl) | Uporaba inhibitorjev PDE7 za zdravljenje motenj gibanja | |
| ZA201208646B (en) | Pharmaceutical combination for the treatment of pain | |
| GB0904285D0 (en) | Compounds for the treatment of metabolic disorders | |
| GB0904044D0 (en) | The treatment of inflammatory disorders and pain | |
| IL225896A0 (en) | Treatment of mecp-2 related disorders | |
| GB0904287D0 (en) | Compounds for the treatment of metabolic disorders | |
| GB0904284D0 (en) | Compounds for the treatment of metabolic disorders | |
| ZA201106076B (en) | Treatment of insulin-resistant disorders | |
| IL215990A0 (en) | Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders | |
| GB201202095D0 (en) | Topical medicament for the treatment of psoriasis | |
| IL225755B (en) | amido derivatives - 6 of epoxymorphinans - a5, 4 for the treatment of pain | |
| IL216491A0 (en) | Combination therapy for the treatment of multiple myeloma | |
| IL219298A0 (en) | Triptans for the treatment of psoriasis | |
| SMT202100576T1 (it) | Dispositivi per il trattamento di lesioni cutanee | |
| PL2493305T3 (pl) | Związki 2-aminoindolowe i sposoby leczenia malarii | |
| IL223219A0 (en) | Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies | |
| ZA201005770B (en) | The treatment of damaged skin | |
| EP2531186A4 (en) | TREATMENT OF HAIR DRESSES | |
| GB0814043D0 (en) | The treatment of skin disorders | |
| PT2456445E (pt) | Agente para o tratamento de condições da pele | |
| GB0703787D0 (en) | The treatment of fibrotic disorders | |
| GB0700210D0 (en) | The treatment of fibrotic disorders |